Literature DB >> 26193242

Time courses of changes of para-, meta-, and ortho-tyrosine in septic patients: A pilot study.

Lívia Szélig1, Szilárd Kun2, Gábor Woth1, Gergő A Molnár2, Zita Zrínyi3, Emese Kátai3, János Lantos4, István Wittmann2, Lajos Bogár1, Attila Miseta3, Csaba Csontos1.   

Abstract

OBJECTIVES: Sepsis is associated with oxidative stress. Due to oxidative stress, three tyrosine isoforms, para-, meta-, and ortho-tyrosine (p-, m-, and o-Tyr), can be formed non-enzymatically in smaller amounts. p-Tyr is mainly formed physiologically in the kidneys through the activity of the phenylalanine hydroxylase enzyme. The three tyrosine isoforms may undergo different renal handling.
METHODS: Twenty septic patients were involved in the study and 25 healthy individuals served as controls. Blood and urine levels of p-, m-, and o-Tyr were measured on admission and four consecutive days.
RESULTS: Serum m-Tyr levels were higher in septic patients than in controls on days 2 (P = 0.031) and 3 (P = 0.035). Serum p-Tyr levels were lower in the cases than in controls on days 1 (P = 0.005) and 2 (P = 0.040), and subsequently normalized due to a day-by-day elevation (P = 0.002). The tendency of urinary m-Tyr concentration was decreasing (P = 0.041), while that of urinary p-Tyr concentration was increasing (P = 0.001). Fractional excretion of m-Tyr (FEm-Tyr) showed a decreasing tendency (P = 0.009), and was, on all days, higher than FEp-Tyr, which remained near-normal, less than 4%. Procalcitonin showed significant correlation with FEm-Tyr (r = 0.454; P < 0.001). DISCUSSION: Our data suggest that the oxidative stress marker m-Tyr and physiologic p-Tyr may be handled differently in septic patients. The excretion of m-Tyr correlates with inflammation. m-Tyr may be actively secreted or produced in the kidney in some patients, whereas the decreased serum level of p-Tyr is a consequence of diminished renal production and not of renal loss.

Entities:  

Keywords:  Acute renal failure; Hydroxyl radical; Oxidative stress; Sepsis; Tyrosine

Mesh:

Substances:

Year:  2016        PMID: 26193242      PMCID: PMC8939338          DOI: 10.1179/1351000215Y.0000000028

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  32 in total

1.  The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies.

Authors:  R A Jörres; O Holz; W Zachgo; P Timm; S Koschyk; B Müller; F Grimminger; W Seeger; F J Kelly; C Dunster; T Frischer; G Lubec; M Waschewski; A Niendorf; H Magnussen
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

2.  Altered balance of the aminogram in patients with sepsis - the relation to mortality.

Authors:  Tomoya Hirose; Kentaro Shimizu; Hiroshi Ogura; Osamu Tasaki; Toshimitsu Hamasaki; Shuhei Yamano; Mitsuo Ohnishi; Yasuyuki Kuwagata; Takeshi Shimazu
Journal:  Clin Nutr       Date:  2013-12-14       Impact factor: 7.324

3.  Formation of ortho-tyrosine by radiation and organic solvents in chicken tissue.

Authors:  L R Karam; M G Simic
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

Review 4.  A role for oxidative stress.

Authors:  Samuel N Heyman; Seymour Rosen; Christian Rosenberger
Journal:  Contrib Nephrol       Date:  2011-09-09       Impact factor: 1.580

5.  Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations.

Authors:  P Dandona; P Mohanty; W Hamouda; H Ghanim; A Aljada; R Garg; V Kumar
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

Review 6.  Critical role for oxidative stress, platelets, and coagulation in capillary blood flow impairment in sepsis.

Authors:  Karel Tyml
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

7.  Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis.

Authors:  Lorraine B Ware; Joshua P Fessel; Addison K May; L Jackson Roberts
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

8.  Selective association of endogenous ouabain with subclinical organ damage in treated hypertensive patients.

Authors:  G Nagy; B Gaszner; É Lányi; L Markó; E Fehér; J Cseh; T Kõszegi; J Betlehem; E Sulyok; A Cziráki; I Wittmann
Journal:  J Hum Hypertens       Date:  2010-03-11       Impact factor: 3.012

9.  Amino acid concentrations in plasma and skeletal muscle of patients with acute hemorrhagic necrotizing pancreatitis.

Authors:  E Roth; G Zöch; F Schulz; J Karner; F Mühlbacher; G Hamilton; W Mauritz; P Sporn; J Funovics
Journal:  Clin Chem       Date:  1985-08       Impact factor: 8.327

10.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

View more
  4 in total

Review 1.  Patient Stratification in Sepsis: Using Metabolomics to Detect Clinical Phenotypes, Sub-Phenotypes and Therapeutic Response.

Authors:  Humma Hussain; Kritchai Vutipongsatorn; Beatriz Jiménez; David B Antcliffe
Journal:  Metabolites       Date:  2022-04-21

Review 2.  Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review.

Authors:  Gergő A Molnár; Szilárd Kun; Eszter Sélley; Melinda Kertész; Lívia Szélig; Csaba Csontos; Katalin Böddi; Lajos Bogár; Attila Miseta; István Wittmann
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  Non-Melanoma Skin Cancers: Biological and Clinical Features.

Authors:  Mauro Cives; Francesco Mannavola; Lucia Lospalluti; Maria Chiara Sergi; Gerardo Cazzato; Elisabetta Filoni; Federica Cavallo; Giuseppe Giudice; Luigia Stefania Stucci; Camillo Porta; Marco Tucci
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

Review 4.  Roles of the tyrosine isomers meta-tyrosine and ortho-tyrosine in oxidative stress.

Authors:  Brett R Ipson; Alfred L Fisher
Journal:  Ageing Res Rev       Date:  2016-03-31       Impact factor: 10.895

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.